Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs112509138 | chr2:242596885 | A/G | 6.19E-11 | 175 | 25.87 | 24.85 | 10.3 | KM Plot |
PCPG | rs112519565 | chr16:1768430 | C/T | 1.76E-11 | 173 | 25.67 | 18.75 | 4.52 | KM Plot |
PCPG | rs112521003 | chr13:114151866 | T/C | 5.47E-12 | 175 | 24.17 | 29.57 | 3.32 | KM Plot |
PCPG | rs112544894 | chr16:89906320 | CTG/C | 0.00018 | 173 | 25.87 | 22.63 | 36.37 | KM Plot |
PCPG | rs112551311 | chr16:1768475 | G/A | 1.76E-11 | 173 | 25.67 | 18.75 | 4.52 | KM Plot |
PCPG | rs112584275 | chr7:66381426 | G/A | 0.000217 | 178 | 24.7 | 29.57 | 33.17 | KM Plot |
PCPG | rs112611466 | chr12:131365662 | G/GGT | 1.12E-7 | 174 | 24.7 | 32.32 | 19.87 | KM Plot |
PCPG | rs112667834 | chr5:33991129 | C/CA | 1.0E-5 | 172 | 24.62 | 30.93 | 25.17 | KM Plot |
PCPG | rs112697287 | chr13:114151949 | T/A | 0.000416 | 176 | 24.23 | 28.95 | 3.7 | KM Plot |
PCPG | rs112704735 | chr9:5911794 | C/A | 6.15E-5 | 177 | 25.87 | 11.85 | 15.07 | KM Plot |
PCPG | rs112716657 | chr3:182611059 | A/C | 9.84E-6 | 175 | 25.87 | 27.23 | 11.78 | KM Plot |
PCPG | rs11274011 | chr13:114183018 | GTGATAAGAGGGTCCTTATGATAAGAGGGTCCTTA/ATGATAAGAGGGTC | 5.45E-12 | 176 | 24.1 | 30.33 | 3.32 | KM Plot |
PCPG | rs112750745 | chr10:69598134 | T/C | 0 | 173 | 25.87 | 18.2 | 2.28 | KM Plot |
PCPG | rs112759844 | chr9:86661483 | C/T | 1.73E-5 | 172 | 26.22 | 23.43 | 10.3 | KM Plot |
PCPG | rs112766597 | chr16:1767859 | C/CT | 0 | 170 | 25.77 | 19.3 | 2.93 | KM Plot |